HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, G. G. Articles by Schorge, J. O. Search for Related Content PubMed PubMed Citation Articles by Rao, G. G. Articles by Schorge, J. O.

Transitional Cell Ovarian Carcinoma in a BRCA1 Mutation Carrier

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas

Address reprint requests to: John O. Schorge, MD, University of Texas Southwestern Medical Center at Dallas, Division of Gynecologic Oncology, 5323 Harry Hines Boulevard, J7.124, Dallas, TX 75390-9032; E-mail: john.schorge{at}utsouthwestern.edu.

ABSTRACT

BACKGROUND: BRCA1 mutation carriers are at high risk of developing epithelial ovarian cancer, but the transitional cell variant has not been previously reported in these patients.

CASE: A nulligravid, perimenopausal woman underwent exploratory laparotomy for a pelvic mass, ascites, and omental caking. Intraoperatively, frozen section of a tumor implant revealed high-grade epithelial ovarian carcinoma. Optimal surgical cytoreduction was performed. The final surgical pathology confirmed International Federation of Gynecology and Obstetrics stage IIIC transitional cell ovarian carcinoma. Her family history was significant for a sister with premenopausal breast cancer and a paternal aunt with ovarian cancer. The patient was counseled and elected to undergo genetic testing. Comprehensive gene sequence analysis detected the germline BRCA1 5382insC mutation.

CONCLUSION: Transitional cell ovarian carcinoma is a rare histologic variant of epithelial ovarian cancer that may occur in BRCA1 mutation carriers.

This article has been cited by other articles:

				B. A. Werness, R. A. DiCioccio, G. G. Rao, and J. O. Schorge Transitional Cell Ovarian Carcinoma in a BRCA1 Mutation Carrier Obstet. Gynecol., August 1, 2002; 100(2): 385 - 385. [Full Text] [PDF]